The musculo-skeletal system medicine sales in Canada demonstrate a gradual decline from 2024 to 2028. In 2024, sales are forecasted at $893.3 million, decreasing year-on-year and reaching $882.3 million in 2028. This indicates a negative Compound Annual Growth Rate (CAGR) over these years. As of 2023, the value was slightly higher, setting the decline in motion from this peak.

Future trends to watch for:

Advancements in personalized medicine and biologics could influence market dynamics.
Potential changes in healthcare policies might impact sales growth.
Aging population trends may drive demand despite the forecasted decline.